Lacosamide Suppliers & Bulk Manufacturers
Available Forms: Tablets/ Oral Solution / Injectable
Available Strengths: 50 mg, 100 mg, 150 mg, 200 mg , 10 mg/mL, 200 mg/20 mL
Reference Brands: Vimpat (USA/EU), Motpoly XR (USA),
Category:
Neurology
Lacosamide is an anti-epileptic (anticonvulsant) medication used for the treatment of partial-onset (focal) seizures in adults and children. It works by enhancing the slow inactivation of voltage-gated sodium channels, stabilizing hyperexcitable neuronal membranes, and reducing repetitive neuronal firing. Lacosamide may also interact with CRMP-2 (collapsin response mediator protein-2), contributing to its anti-seizure effects.
Lacosamide is available in Tablets/ Oral Solution / Injectable
and strengths such as 50 mg, 100 mg, 150 mg, 200 mg , 10 mg/mL, 200 mg/20 mL.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Lacosamide is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Lacosamide can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing